Avoid common mistakes on your manuscript.
Erratum to: J Cancer Res Clin Oncol DOI 10.1007/s00432-013-1483-4
The corresponding author would like to correct the Figs. 1 and 2 and its captions, which were published incorrectly in the original version.
Cetuximab-associated acneiform exanthema. Cetuximab-associated acneiform exanthema is classified according NCI CTCAE3.0
Prophylactic treatment regimen applied to group B and reactive treatment regimen applied to group C
The corrected figures and captions are presented below.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found under doi:10.1007/s00432-013-1483-4.
Rights and permissions
About this article
Cite this article
Wehler, T.C., Graf, C., Möhler, M. et al. Erratum to: Cetuximab-induced skin exanthema: prophylactic and reactive skin therapy are equally effective. J Cancer Res Clin Oncol 139, 1961–1962 (2013). https://doi.org/10.1007/s00432-013-1507-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00432-013-1507-0